Upcoming

Vectras Enprocon IPO

BSE SME · 30 Oct–3 Nov 2026

ShareDownload cardWhatsApp
PRICE BAND₹105
GMP* · 0.00%₹0
SUBSCRIPTION—
ISSUE VALUE₹53.05 Cr
MARKETFRAME SCORE50/100Neutral
Low confidence20% input coverage

Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.

Unofficial GMP premium0.00%
▲ 0.00% since 27 Oct, 9:00 am
0.50.0-0.527 Oct, 9:00 am27 Oct, 3:00 pm

15 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.

Subscription

No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.

GMP premium50/100

0.00% unofficial premium

Subscription—

Subscription unavailable

Institutional (QIB) bids—

Not published yet

Valuation vs peers—

Not in the RHP notes yet

Profit trend—

Not in the RHP notes yet

Where the money goes—

Offer split unavailable

Balance sheet—

Not in the RHP notes yet

Promoter holding—

Not in the RHP notes yet

Sector track record—

Sector not set yet

WHERE THE MONEY GOESMARKETFRAME RHP NOTES
LOT SIZE1200 shares
MINIMUM INVESTMENT₹1,26,000
VECTRAS ENPROCON IPO — COMMON QUESTIONSUPDATED LIVE
What is the GMP of Vectras Enprocon today?

The latest unofficial grey market premium for Vectras Enprocon is ₹0 (0.00% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.

What is the price band of Vectras Enprocon?

The price band is ₹105 per share, as reported by InvestorGain for this BSE SME issue.

When does Vectras Enprocon open and close?

The issue window is 30 Oct–3 Nov 2026. The current status is upcoming.

How much is Vectras Enprocon subscribed?

Live subscription figures are published by BSE once bidding opens.

Is Vectras Enprocon a good IPO to apply for?

Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.

VERIFIED NOW

↑Price band published

CHECK BEFORE APPLYING

!Schedule, price and subscription are from InvestorGain, not checked against BSE

!GMP is unofficial and not verified by NSE

!Read the RHP risk factors before applying

OTHER UPCOMING IPOSLIVE BOARD

Schedule, price band and live subscription data are sourced from InvestorGain for this BSE SME issue, not directly from BSE. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.